Fluorescent in situ hybridization assessment of chromosome 8 copy number in breast cancer

Breast Cancer Research and Treatment

Volumn 38, Issue 2, 1996, Pages 201-208

  Afify, Alaa ^a   Bland, Kirby I ^a   Mark, Hon Fong Louie ^a,b  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

Author keywords

Breast cancer; Cytogenetics; FISH; Fluorescent in situ hybridization; Histopathology

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CARCINOMA IN SITU; CHROMOSOME 8; CLINICAL ARTICLE; CYTOGENETICS; DESMOID TUMOR; DISEASE ASSOCIATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEUKEMIA; LYMPHOMA; MELANOMA; OVARY CARCINOMA; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROSTATE CANCER; SALIVARY GLAND TUMOR; TRISOMY; TROPHOBLASTIC DISEASE;

AGED; ANIMALS; BREAST NEOPLASMS; CATS; CHROMOSOMES, HUMAN, PAIR 8; CYTOGENETICS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; PARAFFIN EMBEDDING; POLYPLOIDY; SPECIMEN HANDLING;

EID: 0029937912     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01806674     Document Type: Article

References (22)

1. Sandberg AA, Ture-Carel C: The cytogenetics of solid tumors: Relation to diagnosis, classification and pathology. Cancer 59: 387-395, 1987
2. Gebhart E, Bruderlein S, Augustus M, Siebert E, Feldner J, Schmidt W: Cytogenetics on human breast cancer. Breast Cancer Res Treat 8: 125-138, 1986
3. Husain SA, Bameza R: Sister chromatid exchange frequency in breast cancer cases. Cancer Genet Cytogenet 61 (2): 142-146, 1992
4. Heim S, Mitelman F: Cancer Cytogenetics. Alan R. Liss, Inc., New York: 1987
5. Ali I, Callahan R: Prognostic significance of genetic alterations in human breast carcinoma. In: Jeffry Cossman (ed.) Molecular Genetics In Cancer Diagnosis. Elsevier Publishing Co., Inc., 1990
6. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA: Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 31: 1333-1335, 1983
7. Mark HFL et al.: Characterization of chromosome 9 and 19 somatic cell and radiation hybrids: a comparison of approaches. Applied Cytogenetics 18: 149-156, 1992
8. Mark HFL: Fluorescent in situ hybridization as an adjunct to conventional cytogenetics. Ann Clin Lab Sci 24: 153-163, 1994
9. Hopman AGN, Van Hooren E, Van De Kaa CA, Vooijs PGP, Ramaekers FCS: Detection of numerical chromosome aberrations using in situ hybridization in paraffin sections of routinely processed bladder cancers. Mod Pathol 4:503-513, 1991
10. Kim SY, Lee JS, Ro JY, Gay ML, Hong WK, Hittelman WN: Interphase cytogenetics in paraffin section of lung tumor by non-isotypic in situ hybridization: Mapping genotype/phenotype heterogeneity. Am J Pathol 142: 307-317, 1993
11. Frable WJ: Thin Needle Aspiration Biopsy (Major Problems in Pathology, Vol. 14). W.B. Saunders, Philadelphia, 1983
12. Miranda RN, Mark HFL, Medeiros LJ: Fluorescent in situ hybridization in routinely processed bone marrow aspirate clot and core biopsy sections. Am J Pathology 145: 1-6, 1994
13. Van Dongen JA, Holland R, Peterse JL, Fentiman IS, Lagios MD, Millis RR, Recht A: Ductal carcinoma in situ of the breast, second EORTC consensus meeting. Eur J Cancer 28: 626-629, 1992
14. Schmitt SJ, Sipen W, Sadowskv NL, Connolly JL, Harris JR: Ductal carcinoma in situ of the breast. N Engl J Med 318: 898-903, 1988
15. Bartkova J, Barnes DM, Millis RR, Gullick WJ: Immunohistochemical demonstration of c-Erb B-2 immunoreactivity and thymidine labelling index in breast carcinoma in situ. Breast Cancer Res Treat 18: 11-17, 1941
16. Kapaun P, Kabisch H, Held KR, Walter TA, Hegwisch S, Zander AR: A typical chronic myelogenous leukemia in a patient with trisomy 8 mosaicism syndrome. Annals of Hematology 66 (1): 57-58, 1993
17. Micale MA: Defining the extent and nature of cytogenetic events in prostatic adenocarcinoma: Paraffin FISH vs. metaphase analysis. Cancer Genet Cytogenet 69: 7-12, 1993
18. Persons DL: Interphase molecular cytogenetic analysis of epithelial ovarian carcinomas. Am J Pathology 142 (3): 733-741, 1993
19. Bullerdiek J, Raebe G, Bartnitzke S, Boschen C, Schloot W: Structural rearrangements of chromosome 8 involving 8q12 a primary event in pleomorphic adenoma of the parotid gland. Genetica 72: 85-92, 1987
20. Fletcher JA, Naeem R, Xiao S, Corson JM: Chromosome aberration in desmoid tumors: trisomy 8 may be a predictor of recurrence. Cancer Genet Cytogenet 79: 139-143, 1995
21. Mark HFL et al.: Constitutional trisomy 8 mosaicism and gestational trophoblastic disease. Cancer Genet and Cytogenet (In press)
22. Bullerdiek J: Trisomy 8 as a recurrent clonal abnormality in breast cancer. Cancer Genet Cytogenet 65: 64-67, 1993